Human medicines European public assessment report (EPAR): Enhertu, trastuzumab deruxtecan, Date of authorisation: 18/01/2021, Revision: 19, Status: Authorised

Human medicines European public assessment report (EPAR): Adempas, riociguat, Date of authorisation: 27/03/2014, Revision: 17, Status: Authorised

Compliance notifications explanation and Q&A

HMPC: overview of assessment work - priority list

EMA decision on adoption by analogy of Commission decision C (2025) 2495

Human medicines European public assessment report (EPAR): Protopic, tacrolimus, Date of authorisation: 27/02/2002, Revision: 29, Status: Authorised

Human medicines European public assessment report (EPAR): Oczyesa, octreotide, Date of authorisation: 30/06/2025, Revision: 1, Status: Authorised

Keeping medicines safe: Reporting side effects can make medicines safer for everyone

Safety of medicines

Q&A clinic on eXtended EudraVigilance Medicinal Product Dictionary (XEVMPD) service - April 2026, Online, European Medicines Agency, Amsterdam, the Netherlands, from 16 April 2026, 15:00 (CEST) to 16 April 2026, 16:00 (CEST)